Full text
PDF














Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BLAINEY J. D. Hexamethonium compounds in the treatment of hypertension. Lancet. 1952 May 17;1(6716):993–996. doi: 10.1016/s0140-6736(52)90641-7. [DOI] [PubMed] [Google Scholar]
- CAMPBELL A. J., GRAHAM J. G., MAXWELL R. D. Treatment of hypertension by oral methonium compounds. Br Med J. 1952 Feb 2;1(4752):251–254. doi: 10.1136/bmj.1.4752.251. [DOI] [PMC free article] [PubMed] [Google Scholar]
- FREIS E. D., FINNERTY F. A., Jr, SCHNAPER N. W., JOHNSON R. L. The treatment of hypertension with hexamethonium. Circulation. 1952 Jan;5(1):20–27. doi: 10.1161/01.cir.5.1.20. [DOI] [PubMed] [Google Scholar]
- GRIMSON K. S., ORGAIN E. S., ROWE C. R., Jr, SIEBER H. A. Caution with regard to use of hexamethonium and "apresoline". J Am Med Assoc. 1952 May 17;149(3):215–220. doi: 10.1001/jama.1952.02930200001001. [DOI] [PubMed] [Google Scholar]
- HAFKENSCHIEL J. H., LINDAUER M. A. 1-Hydrazinophthalazine; apresoline in the treatment of hypertension: a two year study. Circulation. 1953 Jan;7(1):52–57. doi: 10.1161/01.cir.7.1.52. [DOI] [PubMed] [Google Scholar]
- HILKER R. R., RHOADS P. S., BILLINGS C. E. Clinical use of hydralazine and hexamethonium in treatment of hypertension. J Am Med Assoc. 1953 Sep 5;153(1):5–9. doi: 10.1001/jama.1953.02940180007002. [DOI] [PubMed] [Google Scholar]
- JOHNSON R. L., FREIS E. D., SCHNAPER H. W. Clinical evaluation of 1-hydrazinophthalazine (C-5968) in hypertension, with special reference to alternating treatment with hexamethonium. Circulation. 1952 Jun;5(6):833–841. doi: 10.1161/01.cir.5.6.833. [DOI] [PubMed] [Google Scholar]
- MOYER J. H. Hydrallazine (apresoline) hydrochloride; pharmacological observations and clinical results in the therapy of hypertension. AMA Arch Intern Med. 1953 Apr;91(4):419–439. doi: 10.1001/archinte.1953.00240160005002. [DOI] [PubMed] [Google Scholar]
- MOYER J. H., MILLER S. I., FORD R. V. Orally administered hexamethonium chloride in hypertension. J Am Med Assoc. 1953 Jul 18;152(12):1121–1129. doi: 10.1001/jama.1953.03690120037010. [DOI] [PubMed] [Google Scholar]
- PALMER R. S., LOOFBOUROW D., DOERING C. R. Prognosis in essential hypertension; 8-year follow-up study of 430 patients on conventional medical treatment. N Engl J Med. 1948 Dec 23;239(26):990–994. doi: 10.1056/NEJM194812232392602. [DOI] [PubMed] [Google Scholar]
- REUBI F. C. Renal hyperemia induced in man by a new phthalazine derivative. Proc Soc Exp Biol Med. 1950 Jan;73(1):102–102. doi: 10.3181/00379727-73-17591. [DOI] [PubMed] [Google Scholar]
- SCHROEDER H. A. Control of hypertension by hexamethonium and 1-hydrazinophthalazine; preliminary observations. AMA Arch Intern Med. 1952 Apr;89(4):523–540. doi: 10.1001/archinte.1952.00240040002001. [DOI] [PubMed] [Google Scholar]
- SCHROEDER H. A., MORROW J. D. The control of arterial hypertension by hyphex, with an evaluation of other methods of therapy. Med Clin North Am. 1953 Jul;1(NATIONWIDE):991–1008. doi: 10.1016/s0025-7125(16)34973-2. [DOI] [PubMed] [Google Scholar]
- SCHROEDER N. A. The effect of 1-hydrasinophthalasine in hypertension. Circulation. 1952 Jan;5(1):28–37. doi: 10.1161/01.cir.5.1.28. [DOI] [PubMed] [Google Scholar]
- SMIRK F. H., ALSTAD K. S. Treatment of arterial hypertension by penta- and hexamethonium salts; based on 150 tests on hypertensives of varied aetiology and 53 patients treated for periods of two to fourteen months. Br Med J. 1951 Jun 2;1(4717):1217–1228. doi: 10.1136/bmj.1.4717.1217. [DOI] [PMC free article] [PubMed] [Google Scholar]
- TAYLOR R. D., DUSTAN H. P., CORCORAN A. C., PAGE I. H. Evaluation of l-hydrazinophthalazine (apresoline) in treatment of hypertensive disease. AMA Arch Intern Med. 1952 Dec;90(6):734–749. doi: 10.1001/archinte.1952.00240120009002. [DOI] [PubMed] [Google Scholar]
